{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T05:04:48Z","timestamp":1779512688716,"version":"3.53.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004348","name":"Region Stockholm","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007075","name":"European Society for Medical Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010355","name":"Hellenic Society of Medical Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010355","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007231","name":"Cancer Society","doi-asserted-by":"publisher","award":["204053"],"award-info":[{"award-number":["204053"]}],"id":[{"id":"10.13039\/501100007231","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.compbiomed.2025.110790","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T16:28:44Z","timestamp":1754065724000},"page":"110790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PB","title":["The stereotactic radiosurgery-brain prognostic index (SRS-BPI): A novel prognostic index for SRS-eligible lung cancer patients with brain metastases"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2334-444X","authenticated-orcid":false,"given":"A.","family":"Koulouris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8692-6426","authenticated-orcid":false,"given":"M.","family":"Skribek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5285-2200","authenticated-orcid":false,"given":"O.","family":"Grundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gubanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kalaitzidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Lampa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Hydbring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8343-6226","authenticated-orcid":false,"given":"S.","family":"Ekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Tsakonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.compbiomed.2025.110790_bib1","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","article-title":"clinicalguidelines@esmo.org EGCEa. EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours","volume":"32","author":"Le Rhun","year":"2021","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110790_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2015-000024","article-title":"Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers","volume":"1","author":"Berghoff","year":"2016","journal-title":"ESMO Open"},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110790_bib3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO guideline","volume":"40","author":"Vogelbaum","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.compbiomed.2025.110790_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-811161-1.00002-5","article-title":"Brain metastases: epidemiology","volume":"149","author":"Ostrom","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.compbiomed.2025.110790_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102085","article-title":"Clinical features affecting survival in metastatic NSCLC treated with immunotherapy: a critical review of published data","volume":"89","author":"Passaro","year":"2020","journal-title":"Cancer Treat Rev."},{"issue":"25","key":"10.1016\/j.compbiomed.2025.110790_bib6","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1200\/JCO.2005.03.145","article-title":"Current management of brain metastases, with a focus on systemic options","volume":"23","author":"Langer","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110790_bib7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.lungcan.2015.11.011","article-title":"Non-small cell lung cancer patients with brain metastases treated with first-line platinum-doublet chemotherapy: analysis from the European FRAME study","volume":"90","author":"Moro-Sibilot","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.compbiomed.2025.110790_bib8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fonc.2018.00088","article-title":"Brain metastases in oncogene-addicted non-small cell lung cancer patients: incidence and treatment","volume":"8","author":"Remon","year":"2018","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110790_bib9","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ijrobp.2014.10.024","article-title":"Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis","volume":"91","author":"Sahgal","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110790_bib10","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1704795","article-title":"Alectinib versus crizotinib in untreated ALK-positive non-small-cell lung cancer","volume":"377","author":"Peters","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110790_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1913662","article-title":"Overall survival with Osimertinib in untreated, EGFR-mutated advanced NSCLC","volume":"382","author":"Ramalingam","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.compbiomed.2025.110790_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.lungcan.2019.08.010","article-title":"Brigatinib in patients with ALK-positive advanced non-small-cell lung cancer pretreated with sequential ALK inhibitors: a multicentric real-world study (BRIGALK study)","volume":"136","author":"Descourt","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.compbiomed.2025.110790_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejca.2020.03.006","article-title":"Systemic treatment of brain metastases in non-small cell lung cancer","volume":"132","author":"Page","year":"2020","journal-title":"Eur. J. Cancer"},{"issue":"28","key":"10.1016\/j.compbiomed.2025.110790_bib14","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1200\/JCO.22.02561","article-title":"Phase II trial of Atezolizumab combined with Carboplatin and Pemetrexed for patients with advanced nonsquamous non-small-cell lung cancer with untreated brain metastases (Atezo-Brain, GECP17\/05)","volume":"41","author":"Nadal","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110790_bib15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1470-2045(20)30111-X","article-title":"Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial","volume":"21","author":"Goldberg","year":"2020","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110790_bib16","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.annonc.2021.04.008","article-title":"Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189","volume":"32","author":"Rodriguez-Abreu","year":"2021","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110790_bib17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jtho.2022.10.014","article-title":"First-line Nivolumab plus Ipilimumab with chemotherapy versus chemotherapy alone for metastatic NSCLC in CheckMate 9LA: 3-year clinical update and outcomes in patients with brain metastases or select somatic mutations","volume":"18","author":"Paz-Ares","year":"2022","journal-title":"J. Thorac. Oncol."},{"issue":"11","key":"10.1016\/j.compbiomed.2025.110790_bib18","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1038\/s41591-022-01977-y","article-title":"Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial","volume":"28","author":"Gogishvili","year":"2022","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.compbiomed.2025.110790_bib19","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/JTO.0b013e3181b6b6f4","article-title":"Prognostic scores in patients with brain metastases from non-small cell lung cancer","volume":"4","author":"Nieder","year":"2009","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110790_bib20","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","article-title":"Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials","volume":"37","author":"Gaspar","year":"1997","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110790_bib21","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0360-3016(99)00549-0","article-title":"Radiosurgery for brain metastases: a score index for predicting prognosis","volume":"46","author":"Weltman","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110790_bib22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ijrobp.2009.08.025","article-title":"Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients","volume":"77","author":"Sperduto","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110790_bib23","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijrobp.2004.02.017","article-title":"Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems","volume":"60","author":"Lorenzoni","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110790_bib24","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamaoncol.2016.3834","article-title":"Estimating survival in patients with lung cancer and brain metastases: an update of the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA)","volume":"3","author":"Sperduto","year":"2017","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110790_bib25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijrobp.2022.03.020","volume":"114","author":"Sperduto","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110790_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.102069","article-title":"Validation of the ALK-Brain Prognostic Index for patients with ALK-rearranged lung cancer and brain metastases","volume":"8","author":"Zerdes","year":"2023","journal-title":"ESMO Open"},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110790_bib27","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.annonc.2022.03.273","article-title":"Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification","volume":"33","author":"Trapani","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.compbiomed.2025.110790_bib28","series-title":"Springer Series in Statistics","article-title":"The elements of statistical learning: data mining, inference, and prediction","author":"Hastie","year":"2009"},{"key":"10.1016\/j.compbiomed.2025.110790_bib29","series-title":"Springer Series in Statistics","article-title":"Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis","author":"Harrell","year":"2015"},{"key":"10.1016\/j.compbiomed.2025.110790_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110405","article-title":"External validation of the lung-molGPA to predict survival in patients treated with stereotactic radiotherapy for brain metastases of non-small cell lung cancer","volume":"198","author":"Crouzen","year":"2024","journal-title":"Radiother. Oncol."},{"issue":"5B","key":"10.1016\/j.compbiomed.2025.110790_bib31","first-page":"3015","article-title":"Validation of the graded prognostic assessment index for surgically treated patients with brain metastases","volume":"28","author":"Nieder","year":"2008","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110790_bib32","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ijrobp.2007.06.074","article-title":"A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database","volume":"70","author":"Sperduto","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110790_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/02841860802342390","article-title":"Validation of the graded prognostic assessment index for patients with brain metastases","volume":"48","author":"Nieder","year":"2009","journal-title":"Acta Oncol."},{"key":"10.1016\/j.compbiomed.2025.110790_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1748-717X-6-23","article-title":"Validation of the new Graded Prognostic Assessment scale for brain metastases: a multicenter prospective study","volume":"6","author":"Villa","year":"2011","journal-title":"Radiat. Oncol."},{"issue":"14","key":"10.1016\/j.compbiomed.2025.110790_bib35","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.7150\/ijbs.28608","article-title":"Comparison of prognostic indices in NSCLC patients with brain metastases after radiosurgery","volume":"14","author":"Gao","year":"2018","journal-title":"Int. J. Biol. Sci."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110790_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071804","article-title":"ALK-brain prognostic index-preliminary study of a prognostic tool for patients with ALK-rearranged, non-small cell lung cancer and brain metastases","volume":"12","author":"Tsakonas","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110790_bib37","article-title":"A 3-month survival model after Gamma Knife surgery in patients with brain metastasis from lung cancer with Karnofsky performance status <\/= 70","volume":"13","author":"Park","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110790_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98847-3","article-title":"A new prognostic score for predicting survival in patients treated with robotic stereotactic radiotherapy for brain metastases","volume":"11","author":"Stankiewicz","year":"2021","journal-title":"Sci. Rep."},{"issue":"Suppl 4","key":"10.1016\/j.compbiomed.2025.110790_bib39","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.4103\/2152-7806.111296","article-title":"Epidemiology and prognosis of brain metastases","volume":"4","author":"Stelzer","year":"2013","journal-title":"Surg. Neurol. Int."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110790_bib40","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1200\/JCO.2015.62.0138","article-title":"Extended survival and prognostic factors for patients with ALK-rearranged non-small-cell lung cancer and brain metastasis","volume":"34","author":"Johung","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"13","key":"10.1016\/j.compbiomed.2025.110790_bib41","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1016\/S1470-2045(15)00013-3","article-title":"Targeting brain metastases in ALK-rearranged non-small-cell lung cancer","volume":"16","author":"Zhang","year":"2015","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110790_bib42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/JTO.0000000000000069","article-title":"EGFR mutation and brain metastasis in pulmonary adenocarcinomas","volume":"9","author":"Shin","year":"2014","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110790_bib43","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.annonc.2022.12.009","article-title":"clinicalguidelines@esmo.org EGCEa. Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Hendriks","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.compbiomed.2025.110790_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102105","article-title":"EGFR exon 20 insertions in advanced non-small cell lung cancer: a new history begins","volume":"90","author":"Remon","year":"2020","journal-title":"Cancer Treat Rev."},{"issue":"8","key":"10.1016\/j.compbiomed.2025.110790_bib45","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1200\/JCO.2012.44.5353","article-title":"ALK in lung cancer: past, present, and future","volume":"31","author":"Shaw","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110790_bib46","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.annonc.2021.06.001","article-title":"Targeting KRAS in non-small-cell lung cancer: recent progress and new approaches","volume":"32","author":"Reck","year":"2021","journal-title":"Ann. Oncol."},{"issue":"15","key":"10.1016\/j.compbiomed.2025.110790_bib47","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1158\/1078-0432.CCR-22-0383","article-title":"Activity of Adagrasib (MRTX849) in brain metastases: preclinical models and clinical data from patients with KRASG12C-mutant non-small cell lung cancer","volume":"28","author":"Sabari","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110790_bib48","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1470-2045(14)70061-0","article-title":"Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study","volume":"15","author":"Yamamoto","year":"2014","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110790_bib49","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1916623","article-title":"The effect of advances in lung-cancer treatment on population mortality","volume":"383","author":"Howlader","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110790_bib50","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.2002","article-title":"Trends in survival rates of non-small cell lung cancer with use of molecular testing and targeted therapy in Korea, 2010-2020","volume":"6","author":"Chi","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110790_bib51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12916-021-02070-w","article-title":"The value of innovation: association between improvements in survival of advanced and metastatic non-small cell lung cancer and targeted and immunotherapy","volume":"19","author":"Ramagopalan","year":"2021","journal-title":"BMC Med."},{"issue":"10454","key":"10.1016\/j.compbiomed.2025.110790_bib52","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(24)01029-8","article-title":"New promises and challenges in the treatment of advanced non-small-cell lung cancer","volume":"404","author":"Meyer","year":"2024","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.compbiomed.2025.110790_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15113010","article-title":"The association of gross tumor volume and its radiomics features with brain metastases development in patients with radically treated stage III non-small cell lung cancer","volume":"15","author":"Zeng","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110790_bib54","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41698-023-00473-x","article-title":"Radiological artificial intelligence - predicting personalized immunotherapy outcomes in lung cancer","volume":"7","author":"Roisman","year":"2023","journal-title":"npj Precis. Oncol."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525011412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525011412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:12:32Z","timestamp":1779509552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482525011412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":54,"alternative-id":["S0010482525011412"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110790","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The stereotactic radiosurgery-brain prognostic index (SRS-BPI): A novel prognostic index for SRS-eligible lung cancer patients with brain metastases","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110790","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110790"}}